Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mimi Y Kim

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
The New England Journal of Medicine|December 16, 2005
Combined oral contraceptives in women with systemic lupus erythematosusMichelle Petri, Mimi Y Kim, Kenneth C Kalunian, et al.
Arthritis Research & Therapy|February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus NetworkPeter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 VaccinationPeter M Izmirly, Mimi Y Kim, Marie Samanovic, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
The New England Journal of Medicine|December 16, 2005
Combined oral contraceptives in women with systemic lupus erythematosusMichelle Petri, Mimi Y Kim, Kenneth C Kalunian, et al.
Arthritis Research & Therapy|February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus NetworkPeter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 VaccinationPeter M Izmirly, Mimi Y Kim, Marie Samanovic, et al.
Pageof 9